Abstract

Invasive Candida infections represent a significant cause of morbidity and mortality in neonatal intensive care units (NICUs), with a particular impact on preterm and low-birth-weight neonates. In addition to prematurity, several predisposing factors for Candida colonization and dissemination during NICU hospitalization have been identified, including prolonged exposure to broad-spectrum antibiotics, central venous catheters, parenteral nutrition, corticosteroids, H2 antagonist administration, and poor adherence to infection control measures. According to the literature, the implementation of antifungal prophylaxis, mainly fluconazole, in high-risk populations has proven to be an effective strategy in reducing the incidence of fungal infections. This review aims to provide an overview of risk factors for invasive Candida infections and current perspectives regarding antifungal prophylaxis use. Recognizing and reducing people's exposure to these modifiable risk factors, in conjunction with the administration of antifungal prophylaxis, has been demonstrated to be an effective method for preventing invasive candidiasis in susceptible neonatal populations.

MeSH

Intensive Care Units, Neonatal, Candidiasis, Intensive Care, Neonatal, Risk Factors, Intensive Care Units, Candida, Infections

Cited by

• A 10-Year Study of Neonatal Sepsis from Tuen Mun Hospital, Hong Kong. Pathogens, 2025
• Clinical features, risk factors, and outcomes of neonatal invasive candidiasis: a 20-case study series from a tertiary neonatal critical care unit in Oman. Ital J Pediatr, 2025
• A cell wall-targeting urease-derived peptide as a potential antifungal agent against Candida species. Curr Res Microb Sci, 2025
• Characterization and virulence of yeasts associated with neonatal thrush. BMC Microbiol, 2025
• Addressing the silent threat: managing invasive Candida infections in hospitalized newborns. Front Pediatr, 2025
• First report of Candida sojae sepsis in a preterm infant; A new fungal threat in neonatal care. Curr Med Mycol, 2024
• Characterizing neonatal community-acquired invasive fungal infections: Clinical profiles, pathogens, and underlying conditions. Medicine (Baltimore), 2025